“…The vast majority of studies showed that renal function improves after introducing a PSI and lowering or discontinuing CNIs. On average, a decrease in serum creatinine of 25-66% was seen [30,35,36,[40][41][42][43]. A few small studies have shown improvement in dialysis-dependent patients such that dialysis was no longer necessary [31,32].…”
Section: Use Of Proliferation Signal Inhibitors To Reduce Calcineurinmentioning
Proliferation signal inhibitors are important new immunosuppressive agents that have added considerably to the armamentarium allowing further tailored immunosuppression to individualize patient care after heart transplantation.
“…The vast majority of studies showed that renal function improves after introducing a PSI and lowering or discontinuing CNIs. On average, a decrease in serum creatinine of 25-66% was seen [30,35,36,[40][41][42][43]. A few small studies have shown improvement in dialysis-dependent patients such that dialysis was no longer necessary [31,32].…”
Section: Use Of Proliferation Signal Inhibitors To Reduce Calcineurinmentioning
Proliferation signal inhibitors are important new immunosuppressive agents that have added considerably to the armamentarium allowing further tailored immunosuppression to individualize patient care after heart transplantation.
“…Various reports, most with few cases, have evaluated the combination of PSIs with dose-reduced CNI on renal function in HTP. Some studies aimed for CNI dose reduction [107][108][109][110] and others for withdrawal [110][111][112][113][114][115][116][117] after initiating SRL or EVL. The majority of studies showed that renal function improves after introducing a PSI and lowering or discontinuing CNIs.…”
Section: Everolimus In Heart Transplantation Patientsmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.